Epeius Biotechnologies Corporation (Epeius)

Oncology Corporate Profile

HQ Location

475 Huntington Drive
San Marino, CA 91108

Company Description

Scientists at Epeius Biotechnologies have developed the world's first targeted delivery system (TDS) that can transport genes or other therapeutic agents directly to diseased areas in the body. This pathotropic, or disease-seeking, technology has enabled the company to develop Rexin-G, the first tumor-targeted, injectable gene delivery system that has demonstrated remarkable safety and superior single-agent efficacy in clinical trials internationally.

Website: http://www.epeiusbiotech.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
Rexin-G®gene therapy vectorBreast cancerI
Rexin-G®gene therapy vectorPancreatic cancerI

View additional information on product candidates here »

Source: http://www.epeiusbiotech.com

Recent News Headlines

There are no news items to display